Tricida Secures $100M In Debt Financing For Latest Drug
Tricida Inc. has scored $100 million in new financing from life science and technology-focused private equity firm Hercules Capital Inc., the biopharmaceutical company said Friday, as it looks to push forward...To view the full article, register now.
Already a subscriber? Click here to view full article